South America Travel Vaccines Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, and Others) and Application (Domestic Travel and Outbound Travel)

No. of Pages: 104
Report Code: BMIRE00025527
Category: Life Sciences
South America Travel Vaccines Market
Buy Now

The travel vaccines market in SAM is expected to grow from US$ 143.20 million in 2021 to US$ 243.85 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2021 to 2028.

 

The SAM travel vaccines market is segmented into  Brazil, Argentina, and the Rest of SAM. During the forecast period, the region is expected to continue its dominance due to an increase in the prevalence of regional diseases, rapid technological innovations, vaccine development, and an increasing geriatric population. Brazil is the major vaccine manufacturer in the region. The country is self-sufficient for 54% of vaccination needs, including DTP, DT for adults and infants, TT, HepB, and DTP combined vaccines (DTP-HB and DTP-HB-Hib), seasonal influenza vaccine, YF vaccine, and meningo AþC. Brazil is one of the major worldwide producers of the YF vaccine, with the lowest market price. Similar to Brazil, Argentina is also the largest country in the region. Argentina has an upper middle-income economy with a diversified industrial sector. The country’s GDP was US$ 123,369 million in 2021. The GDP of Argentina has grown at a compound rate of 6.8% over the last five years. Major countries contributing to the market's growth include Chile, Colombia, Peru, Cuba, Venezuela, and Bolivia. The countries offer significant growth opportunities for the growth of the market. The factors such as increasing focus on vaccine research, continuous advancements in vaccine development technologies, and increasing government spending on pharmaceutical R&D in the region are expected to boost the travel vaccines market.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM travel vaccines market. The SAM travel vaccines market is expected to grow at a good CAGR during the forecast period.     

 

 SAM Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)

 SAM Travel Vaccines Market Revenue and Forecast to 2028 (US$ Million)

 

SAM Travel Vaccines Market Segmentation              

 

SAM travel vaccines market is segmented into product, application, and country. The SAM travel vaccines market, based on product, is segmented into hepatitis A, hepatitis B, meningococcal vaccines, and others. In 2021, the others segment held the largest share of the market. The SAM travel vaccines market, based on application, is segmented into domestic travel and outbound travel. In 2021, the outbound travel segment held the largest share of the market. Based on country, the SAM travel vaccines market is segmented into Brazil, Argentina, and the Rest of SAM.    

Abbott; GlaxoSmithKline plc; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; and Sanofi are among the leading companies in the travel vaccines market in the region.

South America Travel Vaccines Market Strategic Insights

global-market-strategic-framework
Get more information on this report

South America Travel Vaccines Market Segmentation Analysis

South America Travel Vaccines Market Report Highlights

South America Travel Vaccines Report Scope

Report Attribute Details
Market size in 2021 US$ 143.20 Million
Market Size by 2028 US$ 243.85 Million
CAGR (2021 - 2028) 7.6%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Product
  • Hepatitis A
  • Hepatitis B
  • Meningococcal Vaccines
By Application
  • Domestic Travel and Outbound Travel
Regions and Countries Covered South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Market leaders and key company profiles
  • Abbott
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
Get more information on this report

South America Travel Vaccines Market Country and Regional Insights

south-america-travel-vaccines-market
Get more information on this report

The List of Companies - South America Travel Vaccines Market

  1. Abbott
  2. GlaxoSmithKline plc
  3. Merck & Co., Inc.
  4. Novartis AG
  5. Pfizer Inc.
  6. Sanofi
Frequently Asked Questions
How big is the South America Travel Vaccines Market?

The South America Travel Vaccines Market is valued at US$ 143.20 Million in 2021, it is projected to reach US$ 243.85 Million by 2028.

What is the CAGR for South America Travel Vaccines Market by (2021 - 2028)?

As per our report South America Travel Vaccines Market, the market size is valued at US$ 143.20 Million in 2021, projecting it to reach US$ 243.85 Million by 2028. This translates to a CAGR of approximately 7.6% during the forecast period.

What segments are covered in this report?

The South America Travel Vaccines Market report typically cover these key segments-

  • Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines)
  • Application (Domestic Travel and Outbound Travel)

What is the historic period, base year, and forecast period taken for South America Travel Vaccines Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South America Travel Vaccines Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in South America Travel Vaccines Market?

    The South America Travel Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Who should buy this report?

    The South America Travel Vaccines Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South America Travel Vaccines Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now

    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)